These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Effect of hepatoprotector remaxol infusion on liver function in obstructive jaundice model in rats]. Smirnova NG; Chefu SG; Kovalenko AL; Vlasov TD Eksp Klin Farmakol; 2010 Sep; 73(9):24-7. PubMed ID: 21086649 [TBL] [Abstract][Full Text] [Related]
3. [Effect of preoperative biliary drainage on liver function changes in patients with malignant obstructive jaundice in the low bile duct before and after pancreaticoduodenectomy]. Chen D; Liang LJ; Peng BG; Zhou Q; Li SQ; Tang D; Huang L; Huang JF Ai Zheng; 2008 Jan; 27(1):78-82. PubMed ID: 18184470 [TBL] [Abstract][Full Text] [Related]
4. [The clinical efficacy of a succinate-containing infusion drug during pharmacotherapy for hepatic lesions of varying genesis: results of meta-analysis]. Mazina NK; Mazin PV; Sukhanov DS Ter Arkh; 2013; 85(1):56-61. PubMed ID: 23536947 [TBL] [Abstract][Full Text] [Related]
5. [Hepatic dysfunction correction in patients with obturation jaundice]. Datsenko BM; Tamm TI; Borisenko VB; Kramarenko KA Klin Khir; 2013 Apr; (4):9-12. PubMed ID: 23888709 [TBL] [Abstract][Full Text] [Related]
6. [Prophylaxis of hepatic insufficiency after major hepatic resections]. Khoronenko VÉ; Donskova IuS; Baskakov DS; Drozhzhina OV; Sidorov DV; Lozhkin MV; Petrov LO; Nemtsova ER; Iakubovskaia RI Anesteziol Reanimatol; 2014; 59(4):33-8. PubMed ID: 25549484 [TBL] [Abstract][Full Text] [Related]
7. [Possibilities of tissue repair induction during mechanical jaundice of non-tumor genesis]. Vlasov AP; Zaitsev PP; Bolotskikh VA; Vlasova TI; Davydkin VI; Sheyranov NS; Okunev NA Khirurgiia (Mosk); 2018; (12):57-64. PubMed ID: 30560846 [TBL] [Abstract][Full Text] [Related]
8. [Effectiveness of hepatoprotector geptral in the complex treatment of patients with obstructive jaundice]. Nartaĭlakov MA; Baiazitova GR; Mingazov RS; Chingizova GN; Gabdrakhimov SR Eksp Klin Gastroenterol; 2009; (8):102-7. PubMed ID: 20469686 [TBL] [Abstract][Full Text] [Related]
9. Dehydroepiandrosterone ameliorates hepatocellular damage in obstructive jaundice. Gümüş M; Celebi F; Böyük A; Gürsan N; Akçay F Cell Biochem Funct; 2010 Aug; 28(6):515-20. PubMed ID: 20803708 [TBL] [Abstract][Full Text] [Related]
10. [Prophylaxis of hepatic insufficiency in patients with mechanical jaundice]. Desiateryk VI; Mamchur DV Klin Khir; 2014 Mar; (3):60-4. PubMed ID: 25098004 [No Abstract] [Full Text] [Related]
11. [A critical incident during marathon competition as a result of metabolic decompensation]. Orlov YP; Govorova NV; Glushchenko AV; Efremov EN; Vasilenko YB Klin Med (Mosk); 2017; 95(1):85-9. PubMed ID: 30299072 [TBL] [Abstract][Full Text] [Related]
12. Serum bile acid: an alternative liver function marker in the obstructive jaundice patient. Lalisang TJ Acta Med Indones; 2012 Jul; 44(3):233-8. PubMed ID: 22983079 [TBL] [Abstract][Full Text] [Related]
13. [Estimation of efficacy of the correction methods for hepatic functional disorders in cholestasis of mechanical nature]. Khil'ko SS; Starosek VN; Vlakhov AK Klin Khir; 2005 Oct; (10):16-8. PubMed ID: 16509078 [TBL] [Abstract][Full Text] [Related]
15. Comparative Study of the Results of Operations in Patients with Tumor and Non-Tumor Obstructive Jaundice Who Received and Did Not Receive Antioxidant Therapy for the Correction of Endotoxemia, Glycolysis, and Oxidative Stress. Stupin V; Abramov I; Gahramanov T; Kovalenko A; Manturova N; Litvitskiy P; Balkizov Z; Silina E Antioxidants (Basel); 2022 Jun; 11(6):. PubMed ID: 35740100 [TBL] [Abstract][Full Text] [Related]
16. [Hepatoprotective activity of remaxol in patients with chronic hepatic disorders]. Sologub TV; Goriacheva LG; Sukhanov DS; Romantsov MG; Antonova TV; Iakovlev AA; Radchenko VG; Shul'diakov AA; Rechnik VN; Suzdal'tsev AA; Esaulenko EV; Maksimov SL; Baranova IP Klin Med (Mosk); 2010; 88(1):62-6. PubMed ID: 20369616 [TBL] [Abstract][Full Text] [Related]
17. [Use of remaxol in the combination therapy of post-withdrawal disorders in alcoholic patients with comorbid liver damage]. Bokhan NA; Abolonin AF; Ankudinova IÉ; Kurgak DI; Mandel' AI Ter Arkh; 2012; 84(10):51-5. PubMed ID: 23227501 [TBL] [Abstract][Full Text] [Related]
18. Hepatocyte ultrastructural aspects after preoperative biliary drainage in pancreatic cancer patients with cholestatic jaundice. Fiori E; Macchiarelli G; Schillaci A; Lamazza A; Burza A; Paparelli C; Cavallaro A; Cangemi V Anticancer Res; 2003; 23(6C):4859-63. PubMed ID: 14981936 [TBL] [Abstract][Full Text] [Related]
19. [Criteria of differential assignment of drugs with sorptive and disintoxication properties to patients with obturative icterus of non-tumoral genesis]. Pryluts'kyĭ OI Lik Sprava; 2010; (5-6):105-8. PubMed ID: 21488375 [TBL] [Abstract][Full Text] [Related]
20. [Metabolic correction of bile outflow in patients with obstructive jaundice]. Semenov VB; Iakovlev AIu; Zaĭtsev RM; Smirnova EM; Ulitin DN; Mokrov KV Anesteziol Reanimatol; 2012; (2):58-61. PubMed ID: 22834291 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]